Latest News

Safer alternatives to nonsteroidal antinflamatory pain killers

Building on previous work that showed that deleting an enzyme in the COX-2 pathway in a mouse model of heart disease slowed the development of atherosclerosis, researchers have now extended this observation by clarifying that the consequence of deleting the enzyme mPEGS-1 differs, depending on the cell type in which it is taken away. They are now working on ways to deliver inhibitors of mPGES-1 selectively to the macrophages.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Sensors used to monitor dangerous hits on football field

  • 'Abandoned' stroke survivors need better longer-term care, expert says

  • Black Republicans put most faith in US government

  • Bedside caregivers: Research shows opening visitation access improves patient satisfaction

  • Expectant mothers with epilepsy face tough choices over their medication

  • Possible cause of common dementia found, opening avenues for treatment

  • Lou Gehrig's disease study: Renewing brain's aging support cells may help neurons survive

  • Minutes in Criminal Procedures: Writing Style Influences Judges

  • Greater inequality within UK, USA than some developing countries, trade 'footprint' shows

  • Even mild depressive symptoms result in poorer lumbar spinal stenosis surgery outcome

  •